XML 111 R89.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders' Equity - Narrative (Details) - USD ($)
$ in Thousands
1 Months Ended
Oct. 31, 2023
Dec. 31, 2023
Oct. 06, 2023
Oct. 05, 2023
Dec. 31, 2022
Share-Based Compensation Expense (Details) [Line Items]          
Common stock, authorized (in shares)   350,000,000     350,000,000
Common stock, issued (in shares)   19,093,186 18,930,196 151,441,768 18,046,903
Common stock, outstanding (in shares)   18,292,536 18,199,449 145,595,792 18,046,903
Less: Unamortized deferred financing costs $ 10        
Common Stock          
Share-Based Compensation Expense (Details) [Line Items]          
Common stock, authorized (in shares)   350,000,000     350,000,000